Examination of Serum Amyloid a Protein in Kidney Transplant Patients - Comparison of Serum Amyloid a and C-Reactive Protein for Monitoring the Occurrence of Renal-allograft-related Complications

Hiroshima Journal of Medical Sciences

Volumn 47, Issue 2, 1998, Pages 63-67

  Fukuda, Yasuhiko ^a   Kanbe, Masayuki ^b   Sumimoto, Ryo ^c   Yoneya, Taiko ^b   Takeshita, Takenori ^b   Hoshino, Shuji ^b   Shintaku, Sadanori ^b   Dohi, Kiyohiko ^b  

^a HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c CHUGOKU ROSAI HOSPITAL   (Japan)

Author keywords

C reactive protein; Kidney transplantation; Serum amyloid A protein

Indexed keywords

BIOLOGICAL MARKER; PROTEIN C; SERUM AMYLOID A;

ALLOTRANSPLANTATION; ARTICLE; BLOOD; CYTOMEGALIC INCLUSION BODY DISEASE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION;

BIOLOGICAL MARKERS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PROTEIN C; SERUM AMYLOID A PROTEIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032085807     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bausserman, L.L., Sadaniantz, A. and Saritelli, A.1. 1989. Time course of serum amyloid A response in myocardial infarction. Clin. Chim. Acta 184: 297-305.
2. Bending, E.P. and Eriksen, N. 1977. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Soc. Natl. Acad. Sci. USA 74: 4025-4028.
3. Chaimovitz, C. and Parts, M. 1982. Serum amyloid A levels in patients with infections due to cytomegalovirus, varicella-zoster virus and herpes simplex virus. J. Infect. Dis. 146: 443-446.
4. Eitoku, H., Nomata, Y., Wada, A., Tsubota, N. and Yamada, T. 1993. Studies on serum amyloid A (SAA). Latex agglutination nephelometric immunoassay system for the quantitative of SAA in human serum and its clinical values. Biophysics 37: 19-23.
5. Heidenreich, S., Land, D., Tepel, M. and Rahn, K.H. 1994. Monocyte activation for enhanced tumor necrosis factor-alpha and interleukin 6 production during chronic renal allograft rejection. Transplant. Immunol. 2(1): 35-40.
6. Kestenbaum, R.S., Berlyne, G. and Zimlichman, S. 1991. Acute phase protein, serum amyloid A inhibits IL-6 and TNF-induced fever and hypothalamic PGE2 in mice. Scand.J. Immunol. 34: 179-183.
7. Linke, R.P., Bock, V. and Valet, G. 1991. Inhibition of the oxidation burst response of N - formyl peptide-stimulated neutrophils by serum amyloid A protein. Biochem. Biophys. Res. Commun. 176: 1100-1105.
8. Maury, C.P.J. 1985. Comparative study of serum amyloid A protein and C-reactive protein in disease. Cline. Sci. 68: 233-238.
9. Maury, C.P.J. and Teppo, A.M. 1984. Comparative study of serum amyloid-related protein SAA, C-reactive protein and β2-microglobulin as markers of renal allograft rejection. Clinical Nephrology 22: 284-292.
10. Maury, C.P.J., Hockersted, K., Lautenschlager, I. and Scheinin, T.M. 1987. Monitoring of high-density lipoprotein-associated amyloid A protein after liver transplantation. Transplant. Proc. 19: 3825-3826.
11. Moshage, H.J. 1988. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem. Biophys. Res. Commun. 155: 112-117.
12. Muller, T.F., Trosch, F., Ebel, H., Grussner, R.W.G., Feiber, H., Goke, B., Greger, B. and Lange, H. 1997. Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simutaneous pancreas and kidney transplantation. Transplant. Int. 10: 185-191.
13. Nakayama, T., Sonoda, S. and Urano, T. 1983. Monitoring both serum amyloid A and C-reactive protein as inflammatory markers in infectious diseases. Clin. Chem. 39: 293-297.
14. Raynes, J.G. and Cooper, E. H. 1983. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. Clin. Path. 36: 798-803.
15. Rabies, J.G., Eaglings, S. and MacAdam, K.P. 1991. Acute-phase protein synthesis in human hepatoma cells; differential regulation of serum arnyloid A (SAA) and haptoglobulin by interleukin-1 and interleukin-6. Clin. Exp. Immunol. 83: 448-491.
16. Shainkin-Kestenbaum., Zimlichman, S. and Winkoff, Y. 1982. Serum amyloid A (SAA) in viral infection; rubella, measles and subacute sclerosing panencephalitis (SSPE). Clin. Exp. Immunol. 50: 503-506.
17. Smith, J., Colombo, J. and McDonald, T. 1992. Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non treated cystic fibrous patients. J. Clin. Lab. Anal. 6: 219-224.
18. Smith, J.W. and McDonald, T.L.1992. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monotype conditioned media; the effect of prednisolone. Clin. Exp. Immunol. 90: 293-299.
19. The, T.H. and Van, der. Bij. 1990. Cytomegalovirus antigenemia. Rev. Infect. Dis. 12: s737-744.
20. Whicher, J.T., Chambers, R.E. and Higgrison, J. 1985. Acute-phase response of serum amyloid A protein and C-reactive protein to the common cold and influenza. J. Clin. Pathol. 38: 312-316.
21. Yamada, T., Uchiyama, K., Yakata, M. and Gejyo, F. 1989. Sandwich enzyme immunoassay for serum amyloid A protein (SAA). Clin. Chim. Acta. 179: 169-176.
22. Zimlichman, S., Danon, A. and Nathan, I. 1990. Serum amyloid A an acute phase protein inhibits platelet activation. J. Lab. Clin. Med. 116: 180-186.